LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article ; Online: Development of new strategies for early diagnosis of mucormycosis from bench to bedside.

Walsh, Thomas J / Skiada, Anna / Cornely, Oliver A / Roilides, Emmanuel / Ibrahim, Ashraf / Zaoutis, Theoklis / Groll, Andreas / Lortholary, Olivier / Kontoyiannis, Dimitrios P / Petrikkos, George

Mycoses

2014  Volume 57 Suppl 3, Page(s) 2–7

Abstract: Early diagnosis and initiation of amphotericin B (AmB) for treatment of mucormycosis increases ... Working Group is to improve the clinical and laboratory diagnosis of mucormycosis. The diagnostic tools ... survival from approximately 40% to 80%. The central objective of a new study of the European Confederation ...

Abstract Early diagnosis and initiation of amphotericin B (AmB) for treatment of mucormycosis increases survival from approximately 40% to 80%. The central objective of a new study of the European Confederation of Medical Mycology (ECMM) and the International Society for Human and Animal Mycology (ISHAM) Zygomycosis Working Group is to improve the clinical and laboratory diagnosis of mucormycosis. The diagnostic tools generated from this study may help to significantly improve survival from mucormycosis worldwide. The study has three major objectives: to conduct a prospective international registration of patients with mucormycosis using a well-established global network of centres; to construct a predictive risk model for patients at risk for mucormycosis; and to establish an international archive of specimens of tissues, fluids, and organisms linked from the patients enrolled into the registry that will be used for development of leading edge molecular, proteomic, metabolic and antigenic systems for mucormycosis.
MeSH term(s) Antifungal Agents/therapeutic use ; Databases, Factual ; Diagnostic Imaging ; Early Diagnosis ; Humans ; Microbiological Techniques ; Mucorales/pathogenicity ; Mucormycosis/diagnosis ; Mucormycosis/drug therapy ; Registries ; Risk Assessment ; Societies, Scientific ; Specimen Handling
Chemical Substances Antifungal Agents
Language English
Publishing date 2014-12
Publishing country Germany
Document type Journal Article
ZDB-ID 392487-7
ISSN 1439-0507 ; 0933-7407
ISSN (online) 1439-0507
ISSN 0933-7407
DOI 10.1111/myc.12249
Shelf mark
Ud II Zs.176: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top